D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 46,312 302 World Ranking 2981 National Ranking 131

Research.com Recognitions

Awards & Achievements

2016 - Distinguished Scientist Award, American Heart Association

2011 - Distinguished Fellowship Award, American College of Cardiology (ACC)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Enzyme

His primary areas of study are Pulmonary hypertension, Internal medicine, Endocrinology, Hypoxia and Vasoconstriction. Stephen L. Archer interconnects Respiratory disease, Sildenafil, Hemodynamics, Vascular resistance and Pulmonary artery in the investigation of issues within Pulmonary hypertension. His research on Internal medicine often connects related topics like Cardiology.

His Cardiology research includes themes of Expert consensus and Surgery. His Hypoxia research includes elements of Circulatory system and Antimycin A, Kinase, Mitochondrion, Cell biology. His Vasoconstriction study combines topics from a wide range of disciplines, such as Pharmacology, Potassium channel and Vasodilation.

His most cited work include:

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association (1995 citations)
  • Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association (1362 citations)
  • Cellular and molecular pathobiology of pulmonary arterial hypertension. (1288 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Cardiology, Pulmonary hypertension, Endocrinology and Pulmonary artery. His Vasoconstriction, Hypoxia, Right ventricular hypertrophy, Nitric oxide and Hypoxic pulmonary vasoconstriction investigations are all subjects of Internal medicine research. His work deals with themes such as Anesthesia and Mitochondrion, which intersect with Hypoxia.

The study incorporates disciplines such as Potassium channel and Cell biology in addition to Hypoxic pulmonary vasoconstriction. The Ventricle, Heart failure and Right ventricular failure research Stephen L. Archer does as part of his general Cardiology study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. His Pulmonary hypertension research is multidisciplinary, relying on both Respiratory disease, Lung, Pathology and Hemodynamics, Vascular resistance.

He most often published in these fields:

  • Internal medicine (55.46%)
  • Cardiology (33.18%)
  • Pulmonary hypertension (32.52%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (55.46%)
  • Cardiology (33.18%)
  • Pulmonary hypertension (32.52%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Cardiology, Pulmonary hypertension, Mitochondrion and Mitochondrial fission. His Internal medicine research integrates issues from Endocrinology and Metabolic syndrome. Within one scientific family, Stephen L. Archer focuses on topics pertaining to Diastole under Cardiology, and may sometimes address concerns connected to Cardiac catheterization.

His Pulmonary hypertension study integrates concerns from other disciplines, such as Cancer research, Inflammation, Ventricular function, Pulmonary artery and Fibrosis. The Mitochondrion study combines topics in areas such as Cell, Reactive oxygen species, Hypoxic pulmonary vasoconstriction and Pyruvate dehydrogenase complex. His Mitochondrial fission research is multidisciplinary, incorporating perspectives in mitochondrial fusion, FIS1, Cell cycle and Cell growth.

Between 2014 and 2021, his most popular works were:

  • Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society (492 citations)
  • Pulmonary arterial hypertension: pathogenesis and clinical management. (192 citations)
  • Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine (115 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Enzyme

Stephen L. Archer mainly focuses on Pulmonary hypertension, Internal medicine, Cardiology, Mitochondrion and Cell biology. The various areas that Stephen L. Archer examines in his Pulmonary hypertension study include Cancer research, Inflammation, Pulmonary artery, Fibrosis and Vasodilation. The concepts of his Cancer research study are interwoven with issues in Hypoxia, Lung and Pathogenesis, Pathology.

Stephen L. Archer has researched Cardiology in several fields, including Microtubule and Colchicine. Stephen L. Archer combines subjects such as Vasoconstriction, Hypoxic pulmonary vasoconstriction and Pyruvate dehydrogenase complex with his study of Mitochondrion. His work in the fields of Cell biology, such as Mitochondrial fission, GTPase and Reactive oxygen species generation, intersects with other areas such as Mitophagy and Dynamin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst.
Journal of the American College of Cardiology (2009)

3381 Citations

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement From the American Heart Association

Michael R. Jaff;M. Sean McMurtry;Stephen L. Archer;Mary Cushman.
Circulation (2011)

2140 Citations

Cellular and molecular pathobiology of pulmonary arterial hypertension.

Marc Humbert;Nicholas W Morrell;Stephen L Archer;Kurt R Stenmark.
Journal of the American College of Cardiology (2004)

1834 Citations

A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

Sébastien Bonnet;Stephen L. Archer;Joan Allalunis-Turner;Alois Haromy.
Cancer Cell (2007)

1628 Citations

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst.
Circulation (2009)

1355 Citations

Measurement of nitric oxide in biological models.

Stephen Archer.
The FASEB Journal (1993)

1213 Citations

Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase

Stephen L. Archer;James M.C. Huang;Václav Hampl;Daniel P. Nelson.
Proceedings of the National Academy of Sciences of the United States of America (1994)

954 Citations

Cellular and molecular basis of pulmonary arterial hypertension.

Nicholas W. Morrell;Serge Adnot;Stephen L. Archer;Jocelyn Dupuis.
Journal of the American College of Cardiology (2009)

893 Citations

Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension Comparison With Inhaled Nitric Oxide

Evangelos Michelakis;Wayne Tymchak;Dale Lien;Linda Webster.
Circulation (2002)

722 Citations

An Abnormal Mitochondrial–Hypoxia Inducible Factor-1α–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats Similarities to Human Pulmonary Arterial Hypertension

Sébastien Bonnet;Evangelos D. Michelakis;Christopher J. Porter;Miguel A. Andrade-Navarro.
Circulation (2006)

686 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stephen L. Archer

Marc Humbert

Marc Humbert

University of Paris-Saclay

Publications: 281

Werner Seeger

Werner Seeger

University of Giessen

Publications: 170

Hossein Ardeschir Ghofrani

Hossein Ardeschir Ghofrani

University of Giessen

Publications: 150

Ralph T. Schermuly

Ralph T. Schermuly

University of Giessen

Publications: 148

Jason X.-J. Yuan

Jason X.-J. Yuan

University of California, San Diego

Publications: 133

Norbert Weissmann

Norbert Weissmann

University of Giessen

Publications: 131

Gérald Simonneau

Gérald Simonneau

University of Paris-Saclay

Publications: 124

David Montani

David Montani

University of Paris-Saclay

Publications: 101

Friedrich Grimminger

Friedrich Grimminger

University of Giessen

Publications: 99

Kurt R. Stenmark

Kurt R. Stenmark

University of Colorado Denver

Publications: 96

D. Dunbar Ivy

D. Dunbar Ivy

University of Colorado Denver

Publications: 92

Olivier Sitbon

Olivier Sitbon

University of Paris-Saclay

Publications: 90

Steven H. Abman

Steven H. Abman

University of Colorado Denver

Publications: 85

Robert Naeije

Robert Naeije

Vrije Universiteit Brussel

Publications: 84

Lewis J. Rubin

Lewis J. Rubin

University of California, San Diego

Publications: 77

Evangelos D. Michelakis

Evangelos D. Michelakis

University of Alberta

Publications: 76

Trending Scientists

Roded Sharan

Roded Sharan

Tel Aviv University

Massimo Massa

Massimo Massa

INSEAD

James Lee Hafner

James Lee Hafner

IBM (United States)

Hanspeter Schaub

Hanspeter Schaub

University of Colorado Boulder

Feng Jiao

Feng Jiao

University of Delaware

Peter Gumbsch

Peter Gumbsch

Karlsruhe Institute of Technology

Rolf Daniel

Rolf Daniel

University of Göttingen

Richard Fishel

Richard Fishel

The Ohio State University

Edna Granéli

Edna Granéli

Linnaeus University

Bernard A.J. Roelen

Bernard A.J. Roelen

Utrecht University

David M. Gardiner

David M. Gardiner

University of California, Irvine

L. Michael Romero

L. Michael Romero

Tufts University

Olaf Dellwig

Olaf Dellwig

Leibniz Institute for Baltic Sea Research

Stanley Berent

Stanley Berent

University of Michigan–Ann Arbor

Anton Sculean

Anton Sculean

University of Bern

Julie R. Brahmer

Julie R. Brahmer

Johns Hopkins University

Something went wrong. Please try again later.